[Pharmacology of antipsychotic drugs]].
Bourin
M
M
Université de Nantes, EA 3256 - neurobiologie de l'anxiété et de la dépression, 1, rue Gaston Veil, BP 53508, 44035 Nantes.
D058668:Adrenergic alpha-1 Receptor Antagonists; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000633:toxicity; D000068180:Aripiprazole; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001931:Brain Mapping; D004298:Dopamine / Q000502:physiology; D018491:Dopamine Agonists / Q000494:pharmacology* / Q000633:toxicity; D018492:Dopamine Antagonists / Q000494:pharmacology* / Q000633:toxicity; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D009638:Norepinephrine / Q000502:physiology; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity; D015363:Quinolones / Q000494:pharmacology* / Q000633:toxicity; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D012559:Schizophrenia / Q000503:physiopathology*; D012565:Schizophrenic Psychology
D058668:Adrenergic alpha-1 Receptor Antagonists; D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D010879:Piperazines; D015363:Quinolones; D018340:Receptors, Adrenergic, alpha-1; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole; D004298:Dopamine; D009638:Norepinephrine